TOLVAPTAN TEVA 30 mg, tablet + tolvaptan teva 60 mg, tablet 56 tablets
Active ingredients: Tolvaptan
Commercialized according to BDPMDispensing in France: Prescription only
Tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TOLVAPTAN TEVA 30 mg, comprimé + TOLVAPTAN TEVA 60 mg, comprimé
- Pharmaceutical form
- comprimé et comprimé
- Route of administration
- orale
- Presentation description
- 56 comprimés sous 4 plaquettes (PVC/ACLAR/PVC) contenant 7 comprimés de 30 mg et 7 comprimés de 60 mg
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Jun 2021
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64599993CIP73020527CIP133400930205273Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOLVAPTANcomprimé de 30 mg | 30 mg · un comprimé | SA |
| TOLVAPTANcomprimé de 60 mg | 60 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.